• 1
    Lerman C, Croyle RT, Tercyak KP, Hamann H. Genetic testing: psychological aspects and implications. J Consult Clin Psychol 2002; 70: 78497.
  • 2
    van Korlaar I, Vossen C, Rosendaal F, Cameron L, Bovill E, Kaptein A. Quality of life in venous disease. Thromb Haemost 2003; 90: 2735.
  • 3
    van Korlaar IM, Vossen CY, Rosendaal FR, Bovill EG, Cushman M, Naud S, Kaptein AA. The impact of venous thrombosis on quality of life. Thromb Res 2004; 114: 118.
  • 4
    Rosendaal FR. Risk factors for venous thrombotic disease. Thromb Haemost 1999; 82: 6109.
  • 5
    Rosendaal FR. Venous thrombosis: a multicausal disease. Lancet 1999; 353: 116773.
  • 6
    Machin SJ. Pros and cons of thrombophilia testing: cons. J Thromb Haemost 2003; 1: 4123.
  • 7
    Martinelli I. Pros and cons of thrombophilia testing: pros. J Thromb Haemost 2003; 1: 4101.
  • 8
    Martinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F, Paciaroni K, Leone G, Faioni EM. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: a study of 150 families. Blood 1998; 92: 23538.
  • 9
    Gritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG, Amos CI, Frazier ML, Lynch PM. Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 2005; 23: 190210.
  • 10
    Butow PN, Lobb EA, Meiser B, Barratt A, Tucker KM. Psychological outcomes and risk perception after genetic testing and counselling in breast cancer: a systematic review. Med J Aust 2003; 178: 7781.
  • 11
    Broadstock M, Michie S, Marteau T. Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet 2000; 8: 7318.
  • 12
    Lindqvist PG, Dahlback B. Reactions to awareness of activated protein C resistance carriership: a descriptive study of 270 women. Acta Obstet Gynecol Scand 2003; 82: 46770.
  • 13
    Hellmann EA, Leslie ND, Moll S. Knowledge and educational needs of individuals with the factor V Leiden mutation. J Thromb Haemost 2003; 1: 23359.
  • 14
    Bank I, Scavenius MP, Büller HR, Middeldorp S. Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice. Thromb Res 2004; 113: 712.
  • 15
    Griffin JH, Evatt B, Zimmerman TS, Kleis AJ, Wideman C. Deficiency of protein C in congenital thrombotic disease. J Clin Invest 198; 68: 13703.
  • 16
    Vossen CY, Conard J, Fontcuberta J, Makris M, van der Meer FJ, Pabinger I, Palareti G, Preston FE, Scharrer I, Souto JC, Svensson P, Walker ID, Rosendaal FR. Familial thrombophilia and lifetime risk of venous thrombosis. J Thromb Haemost 2004; 2: 152632.
  • 17
    Tomczak JA, Ando RA, Sobel HG, Bovill EG, Long GL. Genetic analysis of a large kindred exhibiting type I protein C deficiency and associated thrombosis. Thromb Res 1994; 74: 24354.
  • 18
    Bovill EG, Bauer KA, Dickerman JD, Callas P, West B. The clinical spectrum of heterozygous protein C deficiency in a large New England kindred. Blood 1989; 73: 7127.
  • 19
    Spielberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists’ Press, 1974.
  • 20
    Cameron LD, Diefenbach MA. Responses to information about psychosocial consequences of genetic testing for breast cancer susceptibility: influences of cancer worry and risk perceptions. J Health Psychol 2001; 6: 4759.
  • 21
    Schwartz CE, Sprangers MAG, Carey A, Reed G. Exploring response shift in longitudinal data. Psychol Health 2004; 19: 5169.
  • 22
    Sprangers MAG, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci & Med 1999; 48: 150715.
  • 23
    Klein CTF, Helweg-Larsen M. Perceived control and the optimistic bias: a meta-analytic review. Psychol Health 2002; 17: 43746.
  • 24
    Meiser B, Butow P, Friedlander M, Barratt A, Schnieden V, Watson M, Brown J, Tucker K. Psychological impact of genetic testing in women from high-risk breast cancer families. Eur J Cancer 2002; 38: 202531.